The hydrolytic deamination of 5-methylcytosine (5-mC) to thymine (T) is believed to be responsible for the high mutability of the CpG dinucleotide in DNA. We have shown a possible alternate mechanism for mutagenesis at CpG in which Hpall DNA-(cytosine-5) methyltransferase (M.Hpall) can enzymatically deaminate cytosine (C) to uracil
INTRODUCTION
DNA methylation has been suggested to play multiple roles in the development of cancer (1) . The CpG dinucleotide, which is the target for DNA methylation, is markedly underrepresented in the human genome, yet is the site of about one third of all point mutations found in the germline and in cancer (2) (3) (4) . The methylation of C to 5-mC by DNA methyltransferase is believed to play a critical role in the high frequency of C-+T or corresponding G-+A transition mutations found at this dinucleotide (5, 6) . The hydrolytic deamination rate of 5-mC is 2-to 3-fold higher than that of C in double-stranded DNA (7) and 4-to 5-fold higher in single-stranded DNA (8, 9) . However, the increased deamination rate of 5-mC relative to C is not sufficient to account for the 42-fold increase in mutability seen at CpG sites (10) . Rather, it is believed that the G:T mismatch resulting from the deamination of 5-mC is more difficult to repair than the G:U mismatch resulting from C deamination (11) .
We recently presented a possible alternate mechanism to explain the discrepancy between the observed and expected mutational frequency of methylation sites. M.HpaH, in the absence of the methyl donor S-adenosylmethionine (AdoMet), can enzymatically deaminate C to U at a 10 000-fold higher rate than hydrolytic deamination (12) . These results have been repeated and confirmed by Wyszynski et al. (13) with the EcoRII methyltransferase. Zhang and Mathews have presented data that neither M.HpaII nor Sprioplasma CpG methyltransferase can cause deamination of C to U (14) , however, the genetic reversion assay is susceptible to a number of technical difficulties, such as the presence of AdoMet in the enzyme preparation, which can cause failure to see C to U conversion. Deamination of 5mC to T by the human DNA-(cytosine-5) methyltransferase was not detected by high pressure liquid chromatography (15) , however, the genetic reversion assays used in the studies by Shen et al. (12) and Wyszynski et al. (13) are much more sensitive and thus capable of detecting an extremely small conversion of C to U (12, 13) .
There are therefore at least two possible pathways leading to C-+T transition mutations at CpG sites, as shown in Figure 1 . Both the hydrolytic deamination of 5-mC and the enzymatic deamination of C create temporary mismatches in DNA, which can be considered premutagenic lesions until fixation of the mutation by DNA replication. Efficient repair systems exist to prevent the fixation of these premutagenic mismatches. The G:T mismatch has been shown to be repaired by an as yet uncharacterized G:T mismatch specific repair system (16) (17) (18) or by the human homolog of the Escherichia coli mutHLS system (19) . The G:U mismatch is repaired by uracil DNA glycosylase (UDG) (20,2 1) . Despite the existence of highly efficient repair systems, some designed specifically to repair mutations at CpG sites, C-+T transition mutations at CpG sites remain the most common single cause of mutation in the germline and cancer.
While studying the enzymatic deamination of C to U by M.HhaI, we unexpectedly found that the enzyme had a higher affinity for DNA mismatches than for its normal recognition site. We investigated whether the binding ofmethyltransferase to these premutagenic mismatches might block their repair, helping to explain why the recognition sequence for cytosine-5 methyltransferases are mutational hotspots. relAl lac] from Stratagene. Construction of the CCGG-pSV2-neo plasmid used for the reversion assay has been described previously ( 12) . Construction of the CCAG-pSV2-neo and GCGC-pSV2-neo plasmids was by PCR-mediated site-directed mutagenesis using the identical method used to construct the CCGG-pSV2-neo plasmid. The mutant oligodeoxyribonucleotide primers for the CCAGpSV2-neo plasmid were: 5'-GGCTATCGTGGCCAGCCAC-GACGG-3' and 5'-CCGTCGTGGCTGGCCACGATAGCC-3', which changed a leucine (CTG) in the neor gene to proline (CCA), destroying drug resistance. The mutant primers for the GCGC-pSV2-neo plasmid were 5'-ATCCGGCTACGCGC-CCATTCGACC-3' and 5'-GGTCGAATGGGCGCGTAGCC-GGAT-3', which changed a cysteine (TGC) in the neor gene to arginine (CGC).
Genetic reversion assay for measuring cytosine deamination
The reversion assay was identical to the one described by Shen et al. (12) . Mutant pSV2-neo constructs (CCGG, CCAG and GCGC) were incubated with M.HhaI, C8 lS-M.HhaI (purified as described in 21) loading on a gel. The samples were run on a 6% non-denaturing polyacrylamide gel for 2 h at 80 V. Gels were dried, exposed to film and scanned using a Radioanalytic Imaging System (AMBIS Inc., San Diego, CA).
Conditions to obtain data for the off-rate calculations were identical to those above, except that 2 pmol radiolabeled oligonucleotide was preincubated for 30 min in the presence of 100 jM S-adenosylhomocysteine (AdoHcy) and then 200 pmol unlabeled oligonucleotide was added at various times prior to loading on the gel.
Covalent trapping of M.HhaI with 5-fluorocytosine (FdC) and This procedure was modified from Smith et al. (15) . The following oligonucleotides were annealed to the bottom strand used in the gel shift assays and radiolabeled as described above. 
Methylation of U determined by reversion assay
The reversion assay mentioned previously (12) for determining the cytosine deamination rate was applied here with little modification. The mutant NeoR plasmid, CCGG-pSV2-neo, was first incubated with M.Hpa II (New England Biolabs) in the absence of AdoMet for 16 h at 37°C. This reaction was stopped by a phenol/chloroform extraction and the plasmids were isolated by NaOAc/EtOH precipitation. The second incubation was done under the same conditions as the first except for the addition of 80 pM AdoMet. The plasmids purified from the second incubation were resuspended in TE buffer. These plasmids were then ready for electrotransformation into E.coli strain NR8051 (ung+). Following plating of the transformants on either ampicillin or kanamycin plates, the reversion frequency was scored by comparing ampicillin resistance with kanamycin resistance. This experiment could not be performed with M.HhaI because E.coli NR8051 transformed with M.HhaI-methylated pSV2-neo were not viable, presumably due to restriction of the M.HhaI methylated plasmid.
Blockage of UDG repair in vitro GCGC-pSV2-neo was incubated with M.HhaI in the absence of AdoMet as mentioned above in order to generate -GUGCmutations. The DNA was purified by phenol/chloroform extraction and ethanol precipitation. The treated GCGC-pSV2-neo plasmid (100 ng) containing -GUGC-mutations was then incubated with serial dilutions of M.HhaI, C81S-M.HhaI or M.Hpall in 10 p1 reaction containing 50 mM Tris-HCl (pH 7.5), 10 mM EDTA, 0.5 mM D1T, 0.2 ig/pl BSA and 0.25 U uracil DNA glycosylase (Boehringer Mannheim), which was added last. Following a 1 h incubation at 37°C, the plasmid was again purified by phenol/chloroform extraction and ethanol precipitation' The purified plasmid was then transformed into E.coli NR8052 (ung) and the reversion frequency was scored.
RESULTS
Deamination of C to U by M.HhaI The ability of DNA methyltransferase to deaminate C to U was measured with a sensitive genetic reversion assay (12) . Sitedirected mutagenesis was used to create a M.HhaI site (GCGC) in the neor gene that destroyed its ability to confer kanamycin resistance. Resistance to kanamycin could be restored by mutation of the GCGC site to GTGC. Additional plasmids were constructed with a CCGG (CCGG-pSV2-neo) and a CCAG target site (CCAG-pSV2-neo) to test for site-specific mutagenesis. CCGG-pSV2-neo was only mutated by M.HpaII and GCGC-pSV2-neo was only mutated by M.HhaI (Table 1) . Therefore, both plasmids were mutated only by the methyltransferase recognizing their specific target sequence. A control, CCAG-pSV2-neo, which was recognized by neither methyltransferase, was not mutated, even though conversion of the inner C to T would have been expected to restore resistance to kanamycin. Table 1 The ability of methyltransferases to methylate C is dependent upon the formation of a covalent bond between a cysteine residue on the enzyme and the 6-position of the target C (27, 28) . Studies using M.EcoRII have shown that mutation of the catalytic cysteine leads to an inability to deaminate C (13). The catalytic cysteine at codon 81 of M.HhaI was replaced by serine (C81S M.HhaI) in order to show the dependence of mutation on the covalent interaction of methyltransferase with the C ring (21) . This mutant methyltransferase could not induce reversion of any of the pSV2-neo plasmids (Table 1) . These studies extend our earlier work with M.HpaH (12) to show that M.HhaI can also induce deamination of C to U and that enzymatic deamination is dependent on the sequence specificity of the methyltransferase and the catalytic cysteine.
Binding of methyltransferase to DNA mismatches DNA methyltransferase can create two possible premutagenic mismatches in which either U or T are paired with the G originally paired with the target C (Fig. 1) . The interaction of methyltransferase with these DNA mismatches was studied next. Previous studies which have investigated the target sequence requirements for DNA methyltransferase used C as the target base for methylation (29) , however, no studies have been done in which the target C had been replaced by a mispair. The interaction of M.HhaI with its target sequence GCGC and appropriate mismatches was examined by gel shift assays ( Fig.  2A and B) . Preliminary experiments showed an increased binding of the enzyme to hemimethylated rather than unmethylated oligonucleotides (data not shown), therefore, hemimethylated oligonucleotides were used for the following experiments. The target C was replaced by either U or T and preincubated with M.HhaI to allow the binding to reach equilibrium. Figure 2A shows gel shift assays in which a constant concentration of M.HhaI and decreasing concentrations of the target oligonucleotide were used. Surprisingly, M.HhaI had a higher affmnity for a G:U and a G:T mismatch than a G:C target, as shown by the incrptsed intensities of the band containing its bound oligonucleotide. Figure 2A also shows that DNA containing an abasic site at the recognition sequence interacted strongly with the enzyme. Binding studies were also performed using the mutant C8 1S M.HhaI, which is unable to form a covalent bond with the target C (data not shown). These results showed that the mutant enzyme bound to DNA mismatches with approximately equal affinity as the wild-type enzyme, showing that formation of the complex did not require the establishment of a covalent bond.
The radioactivity in the bound and free bands shown in Figure  2A was scanned and the ratio used to quantitate the amount of bound/free oligonucleotide for Scatchard analysis to calculate the dissociation constants Kd (Fig. 2B) The rate at which the M.HhaI-DNA mismatch complexes dissociated was determined by incubating labeled oligonucleotide with M.HhaI to allow complex to form and then adding an excess of identical unlabeled competitor oligonucleotide. The off-rate under conditions used to calculate the Kd was too fast to be measured by gel shift assay and these were measured in the presence of 100 ,uM AdoHcy, which slowed the dissociation rate significantly (Fig. 3) . Thetl/2 and k0ff (ln2/t½/) for the normal target 5-mC, the product of the methyltransferase reactio off-rate of the G:T mismatch may also account f affinity by methyltransferase when compared with 1 G:U and abasic site (Fig. 2B ).
Studies were also done using M.HpaII in order phenomena described were unique to M.HhaI ( property of DNA-(cytosine-5) methyltransferasev nucleotide identical to the one used in the previous the exception of altering the target sequence to recognition sequence for M.HpaII) was used. Ag. affmiity for a G:U mismatch in comparison with ti was observed (data not shown). However, the M.Hpall overall was -10-fold less than M.HhaI. Tht both G:C and G:U in the presence ofAdoHcy were al equal to each other and were roughly twice as fast a (data not shown).
Methylation of U to T by methyltransferase Since M.HhaI had an increased binding affin mismatches ( Fig. 2A) , we determined whether meth might be catalytically active upon a G:U mismatch a U to T. The C analog FdC has been used previous covalently bound methyltransferase intermediate (1 demonstrate in Figure 4 the covalent interaction (Fig. 4) could be methylated in DNA. The CCGG-pSV2-neo plasmid was also incubated only with M.HpaII and AdoMet in order to prove that these results were not due to the increased hydrolytic deamination rate of 5-mC compared with C. The reversion assay was used to show evidence that U could be methylated to T. The CCGG-pSV2-neo was first incubated with M.HpaII in the absence of AdoMet in order to generate G:U mismatch mutations. The treated plasmid was purified and subjected to a second incubation with M.HpaII in the absence or presence of AdoMet (80 gM) as described in Materials and Methods. After the second treatment the plasmid was electrotransformed into E.coli NR8051 (ung+), which repair G:U, but not G:T, mismatches. A control experiment without the first incubation, indicated by None, was done in order to determine the increased reversion frequency due to the methylation of C to 5mC.
Methyltransferase blocks DNA repair in vitro The ability of DNA methyltransferase to block repair of premutagenic lesions was next examined (Fig. 5) . The GCGCpSV2-neo plasmid was incubated with M.HhaI in the absence of AdoMet to enzymatically create G:U mismatches, which were detected by our reversion assay after transfection into E.coli deficient for repair by UDG. Incubation of the U-containing plasmids with UDG prior to transfection resulted in almost complete repair of the lesions, since no increase in mutational frequency relative to untreated plasmids was seen. Addition of increasing concentrations of wild-type or mutant. enzyme to plasmids before addition of the UDG led to progressive inhibition [Enzyme] gM Figure 5 . Blockage of uracil DNA glycosylase by M.HhaI in vitro. The mutant GCGC-pSV2-neo plasmid was incubated with M.HhaI in the absence of AdoMet in order to generate -GUGC-premutagenic lesions and then the mutated plasmid was purified. The plasmid (100 ng) containing -GUGCmutations was incubated in a 10 p1 reaction with 0.25 U UDG in the presence of serially diluted M.HhaI, C8 I S M.HhaI or M.HpaII at 37°C for 1 h. M.HpaII, which does not recognize the target sequence, acts as a control for the sequence specificity ofUDG blockage by methyltransferase. The incubation was stopped by the addition of phenol and the plasmid was again purified. The plasmid was then electrotransformed into Ecoli NR8052 (ung-) and the reversion frequency determined as described in Materials and Methods. Treated plasmid not incubated with UDG was transformed in order to determine the number of uracil mutations originally created and the percentage of UDG repair blockage was calculated from a comparison of the reversion frequencies. The value for 100% blockage was determined from plasmid treated with M.HhaI but not UDG.
of the repair enzyme (Fig. 5) . The binding of either enzyme to the mismatch therefore appeared capable of masking the premutagenic lesion. Figure 5 (13) indicate that U was unlikely to be the intermediate for C-+T transition mutations in E.coli. The evidence was that E.coli deficient for repair of U had about the same rate of mutation at methylation sites as E.coli proficient in repairing U. However, our data raise the possibility that methyltransferase cannot only induce deamination of C to U, but can also block the repair of U by UDG.
We have demonstrated the role of methyltransferase in the enzymatic deamination of C to U by showing the sequence specificity of the deamination reaction by M.HpaII and M.HhaI. We also showed the dependence of enzymatic deamination on the catalytic cysteine of methyltransferase, which forms a covalent intermediate with the target C.
Studies of the binding of methyltransferase to different DNA mismatches may give insight into the interaction between methyltransferase and DNA. It has been shown that M.HhaI 'flips' the target C out of the DNA helix (35) , so that the energy associated with removing the target C from the DNA helix may be important in determining the binding affinity of methyltransferase. The higher affinity of methyltransferase for G:U and G:T mismatches compared with the native G:C target may be explained by the lower energy associated with removing a mispaired U or T from the DNA helix. It has been shown that there is an inverse correlation between the binding affinity of M.HhaI and the strength of the interaction of the target base pair (36) . Therefore, it may be more energetically unfavorable to remove the target C from double-stranded DNA than to remove a target base from a DNA mismatch.
Interactions ofCys8l in the catalytic domain ofmethyltransferase apparently play a minor role in determining the binding affinity of the enzyme. Although previous studies have shown that substitution of this Cys8l with other amino acids resulted in a change in the binding affinity of methyltransferase (22, 37) , complete removal of the target base and the creation of an abasic site did not decrease, but rather increased, the binding affinity of methyltransferase for the substrate. The identical binding affinities of methyltransferase for U and an abasic site shown in our work suggest that interactions of the catalytic pocket of methyltransferase with the 'flipped' target base have little, if any, effect in determining the binding affinity. Furthermore, replacement of the catalytic Cys8l in M.HhaI with serine again showed a higher binding affinity for G:U or G:T mismatches compared with the normal G:C target (data not shown). Therefore, the catalytic interactions of methyltransferase with DNA fail to play a major role in the binding affinity. In fact, it is unclear whether the mismatched base rests in the catalytic site of the enzyme. Structural studies of a G:T mismatch indicate that T is shifted into the major groove of the DNA (38), however, methyltransferase extracts the target C from the DNA helix through the minor groove (35) . If the mismatched base is to be 'flipped' into the catalytic pocket it must go through the stacked bases of the DNA helix, which seems sterically unfavorable.
The off-rates ofG:C, the G:U mismatch and the abasic site from the enzyme were identical. However, the rapid dissociation of the G:T mismatch from methyltransferase not only explains its lower affinity when compared with G:U and the abasic site, but may also show the importance of the methyl group on the 5-position of the target base for dissociation of the DNA-methyltransferase complex. The low affinity of methyltransferase for a 5-mC in the target base position (data not shown; 25) is most likely due to rapid dissociation.
The binding of G:U mismatches by methyltransferase can lead to catalysis. We were able to trap the covalent interaction between M.HhaI and FdU. Furthermore, both M.HhaI and M.HpaII can convert U to T by transferring a methyl group from AdoMet to the 5-position of U. Methylation of U indicates that the mismatched base must be flipped out of the DNA helix into the catalytic pocket of methyltransferase. The methylation of U by methyltransferase was much less efficient than that of C and the key to methyltransferase specificity may be Glull9, which interacts with the target C (35) . In studies done with thymidylate synthase, which methylates dUMP, an asparigine was changed to either aspartate or glutamate. These mutant thymidylate synthetase enzymes were able to methylate dCMP (39, 40) . It is possible that substitution of Glul 19 with glutamine may change the specificity of methyltransferase for methylation of U.
A major reason that it seems unlikely that C-+T transition mutations occur through a U intermediate is that U in the DNA is very efficiently removed by UDG (20) . We have shown that repair of a G:U mismatch is blocked by the binding of methyltransferase, however, it may also be possible that methylation of the G:U mismatch to a G:T mismatch would create a premutagenic lesion which is more difficult to repair. In conjunction with our previous work, one may contemplate the possibility that methyltransferase can deaminate C to U and then transfer a methyl group to U, creating T, in a consecutive enzymatic reaction. This two step enzymatic reaction consisting of a deamination followed by methylation presents another possible pathway for C-+T transition mutations not shown in Figure 1 . It is also possible that methyltransferase could methylate a U created by the hydrolytic deamination of C.
DNA repair has recently gained much attention, however, an important unanswered question relates to why DNA repair is not 100% efficient. Recently it has been shown that regions in thep53 tumor suppressor gene and PGKI gene undergo different rates of repair and sites in the p53 gene which were hotspots for mutation corresponded to sites which were slow in DNA repair (41, 42) .
Previous studies have shown that the sequence context determines the efficiency of UDG (43) , which could offer one explanation as to why certain DNA sequences are slow in repair. We propose the hypothesis that methyltransferase and other DNA binding proteins may block DNA repair. The excision of U from DNA can be blocked by the X repressor and Lac repressor in vitro (44) . Other DNA mismatch binding proteins have been shown to block DNA repair. The HexA gene of Streptococcuspneumoniae, which is homologous to MutS, confers a mutator phenotype when expressed in E.coli by blocking the endogenous Mut repair system (45) . Also, hMSH2, the recently identified human homolog of MutS, caused a dominant mutator phenotype when expressed in E.coli (46) . Mutation of hMSH2 may be responsible for hereditary non-polyposis colorectal cancer (Lynch syndrome) by binding DNA mismatches and interfering with their normal repair (19, 46, 47) . We have shown that a DNA binding protein, DNA-(cytosine-5) methyltransferase, unexpectedly binds to DNA mismatches in its recognition sequence with a higher affinity than its normal G:C target. These DNA mismatches, which can be considered premutagenic lesions, were protected from DNA,repair by the binding ofmethyltransferase and thereby may contribute to the mutability of the methyltransferase target sequence. Thus blockage of DNA repair by DNA binding proteins may be a common event in the genesis of mutations.
The rate of hydrolytic deamination of 5-mC in double-stranded DNA is more than sufficient to account for the mutational frequency seen at the CpG dinucleotide (7). However, the mutational frequency at CpG dinucleotides, which is 42-fold higher than observed at C in other sequence contexts (10) , cannot be explained solely by the 2-to 3-fold increased deamination rate of 5-mC relative to C (7). Furthermore, studies on mutations in the globin genes suggest that unmethylated CpG dinucleotides are also susceptible to mutation (48) . Thus, several different mechanisms may be responsible for the mutability of the CpG dinucleotide: the hydrolytic deamination of 5-mC to T, the enzymatic deamination of C to U by methyltransferase, the methylation of U to T by methyltransferase and the blockage of repair of DNA mismatches by the binding of methyltransferase. Further studies are required in order to determine the relative importance and contributions of these pathways in the mutability of the CpG dinucleotide.
